JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB62650

Anti-CD79a antibody [HM57]

3

(2 Reviews)

|

(4 Publications)

Mouse Monoclonal CD79A antibody. Suitable for IHC-P and reacts with Human samples. Cited in 4 publications. Immunogen corresponding to Synthetic Peptide within Human CD79A aa 200 to C-terminus.

View Alternative Names

CD79a, IGA, MB1, CD79A, B-cell antigen receptor complex-associated protein alpha chain, Ig-alpha, MB-1 membrane glycoprotein, Membrane-bound immunoglobulin-associated protein, Surface IgM-associated protein

1 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD79a antibody [HM57] (AB62650)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD79a antibody [HM57] (AB62650)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) of human tonsil staining CD79a with ab62650.

  • 519 FITC

    FITC Anti-CD79a antibody [HM57]

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

HM57

Isotype

IgG1

Carrier free

No

Reacts with

Human

Applications

IHC-P

applications

Immunogen

Synthetic Peptide within Human CD79A aa 200 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

P11912

style
left-column

Alternative Products

Primary Antibodies

AB237950

Anti-CD79a antibody [rIGA/764] - BSA and Azide free

Recombinant

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD79a antibody [rIGA/764] - BSA and Azide free (AB237950)

  • 0
  • 0
Primary Antibodies

AB238096

Anti-CD79a antibody [rIGA/764]

Recombinant

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD79a antibody [rIGA/764] (AB238096)

  • 0
  • 0
Primary Antibodies

AB16698

Anti-CD79a antibody [SP18]

RabMAb

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD79a antibody [SP18] (AB16698)

  • 1
  • 1
Primary Antibodies

AB133483

Anti-CD79a antibody [EPR3619]

RabMAb|Recombinant|KO Validated

Flow Cytometry - Anti-CD79a antibody [EPR3619] (AB133483)

  • 0
  • 0
Primary Antibodies

AB79414

Anti-CD79a antibody [EP3618]

RabMAb|Recombinant|KO Validated

Immunocytochemistry/ Immunofluorescence - Anti-CD79a antibody [EP3618] (AB79414)

  • 0
  • 0
Primary Antibodies

AB239891

Anti-CD79a antibody [EP3618] - BSA and Azide free

RabMAb|Recombinant|KO Validated

Immunocytochemistry/ Immunofluorescence - Anti-CD79a antibody [EP3618] - BSA and Azide free (AB239891)

  • 5
  • 2

Complementary Products

Assay Kits

AB309430

Human CD79a ELISA Kit

Sandwich ELISA - Human CD79a ELISA Kit (AB309430)

  • 0
  • 0
Primary Antibodies

AB64088

Anti-CD20 antibody [SP32]

BOND RX™ Validated|20ul selling size|RabMAb|Advanced Validation|Recombinant|KO Validated

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD20 antibody [SP32] (AB64088)

  • 5
  • 12
Primary Antibodies

AB133616

Anti-CD4 antibody [EPR6855]

BOND RX™ Validated|RabMAb|Recombinant|Lab Essentials|20ul selling size|Advanced Validation

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD4 antibody [EPR6855] (AB133616)

  • 5
  • 19
Primary Antibodies

AB16699

Anti-CD5 antibody [SP19]

BOND RX™ Validated|RabMAb|Recombinant|20ul selling size

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD5 antibody [SP19] (AB16699)

  • 0
  • 0
Primary Antibodies

AB237709

Anti-CD8 alpha antibody [CAL66]

BOND RX™ Validated|20ul selling size|RabMAb|Advanced Validation|Recombinant

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD8 alpha antibody [CAL66] (AB237709)

  • 5
  • 2
style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/500", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval before commencing with IHC staining protocol." } } }
style
left-column
style
left-column

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Purification notes
Purified IgG prepared by affinity chromatography on Protein A from tissue culture supernatant
Storage buffer
pH: 7.4 Preservative: 0.09% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CD79a also known as Ig-alpha or MB-1 is a component of the B cell antigen receptor (BCR) complex. It is a transmembrane protein with a molecular mass of approximately 47 kDa. CD79a is part of a heterodimer with CD79b and is mainly expressed on the surface of B lymphocytes. This protein plays a critical mechanical role in signaling transduction through the BCR by associating with membrane-bound immunoglobulin molecules helping to initiate the immune response upon antigen binding.
Biological function summary

This protein acts as an essential mediator in the immune system. CD79a together with CD79b forms part of the BCR complex critical for B cell development and maturation. The BCR complex activates signaling cascades that influence B cell fate decisions such as proliferation differentiation and apoptosis. By transmitting signals from the BCR CD79a helps regulate these cellular functions necessary for efficient immune defense.

Pathways

CD79a plays a pivotal role in the B cell receptor signaling pathway. This pathway involves signaling molecules such as spleen tyrosine kinase (SYK) and phosphoinositide 3-kinase (PI3K) which are activated upon BCR engagement. CD79a acts in concert with other proteins including CD79b and the IgM receptor facilitating downstream signaling cascades that ensure proper B cell responses. Its role is important for linking extracellular antigen recognition to intracellular signaling events.

CD79a is significant in conditions like B cell lymphomas and certain immunodeficiencies. Abnormal expression or mutations in CD79a are associated with some types of non-Hodgkin lymphoma. The protein's interaction with CD79b is particularly relevant as alterations in these proteins' function or expression can impact B cell development and lead to pathogenesis in lymphoproliferative disorders. Consequently CD79a serves as an important biomarker and potential therapeutic target in these diseases.
style
left-column
style
left-column

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

Target data

Required in cooperation with CD79B for initiation of the signal transduction cascade activated by binding of antigen to the B-cell antigen receptor complex (BCR) which leads to internalization of the complex, trafficking to late endosomes and antigen presentation. Also required for BCR surface expression and for efficient differentiation of pro- and pre-B-cells. Stimulates SYK autophosphorylation and activation. Binds to BLNK, bringing BLNK into proximity with SYK and allowing SYK to phosphorylate BLNK. Also interacts with and increases activity of some Src-family tyrosine kinases. Represses BCR signaling during development of immature B-cells.
See full target information CD79A
style
left-column

Publications (4)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in veterinary science 8:795126 PubMed34977226

2021

Case Report: Primary Diffuse Leptomeningeal Oligodendrogliomatosis in a Young Adult Cat.

Applications

Unspecified application

Species

Unspecified reactive species

Elisa Chludzinski,Christina Puff,Jürgen Weber,Marion Hewicker-Trautwein

Pathogens (Basel, Switzerland) 9: PubMed32456293

2020

Analysis of the Leukocyte Response in Calves Suffered from Pneumonia.

Applications

Unspecified application

Species

Unspecified reactive species

Katarzyna Dudek,Dariusz Bednarek,Urszula Lisiecka,Anna Kycko,Michał Reichert,Krzysztof Kostro,Stanisław Winiarczyk

Frontiers in immunology 11:100 PubMed32117254

2020

Novel Engraftment and T Cell Differentiation of Human Hematopoietic Cells in SCID Pigs.

Applications

Unspecified application

Species

Unspecified reactive species

Adeline N Boettcher,Yunsheng Li,Amanda P Ahrens,Matti Kiupel,Kristen A Byrne,Crystal L Loving,A Giselle Cino-Ozuna,Jayne E Wiarda,Malavika Adur,Blythe Schultz,Jack J Swanson,Elizabeth M Snella,Chak-Sum Sam Ho,Sara E Charley,Zoe E Kiefer,Joan E Cunnick,Ellie J Putz,Giuseppe Dell'Anna,Jackie Jens,Swanand Sathe,Frederick Goldman,Erik R Westin,Jack C M Dekkers,Jason W Ross,Christopher K Tuggle

Veterinary immunology and immunopathology 196:5-13 PubMed29695325

2018

Cruciate ligament degeneration and stifle joint synovitis in 56 dogs with intact cranial cruciate ligaments: Correlation of histological findings and numbers and phenotypes of inflammatory cells with age, body weight and breed.

Applications

Unspecified application

Species

Unspecified reactive species

Anna-Katharina Döring,Johannes Junginger,Marion Hewicker-Trautwein
View all publications
style
left-column
style
left-column
style
right-column

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com